Veriheal

SEPTEMBER 22, 2021

If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina. About the NC Medical Cannabis Legalization Bill.

Legalization 124

Legalization Patients Cultivation Legislation 124

Veriheal

JANUARY 21, 2025

have a long history rooted in protecting workers from dangerous and unfair work conditions. To address these issues, groups of workers started organizing into unions, creating a united front to demand better conditions, wages, and benefits. Background on Labor Unions in the U.S. Labor unions in the U.S. million U.S.

Law 97

Law Environment Conditions Safety 97

Veriheal

NOVEMBER 21, 2023

Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments. With all this information at their fingertips, individuals can personalize their consumption routine to match their lifestyles and conditions. See you in 2024!

Research and Development 110

Research and Development Consumption Education Data 110

Veriheal

MARCH 23, 2024

The law is set to take effect in June 2024 , marking a major shift in Ukraine’s healthcare policy. Medical professionals have suggested that cannabis could be a valuable tool in treating these conditions. This European trend shows a growing acceptance of cannabis as a medical treatment.

Legalization 111

Legalization Chronic Pain Sleep Policy 111

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 23, 2021

By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes.

Programs 100

Programs Data Events Collective 100

Veriheal

MAY 19, 2023

Chronic pain stemming from nerve damage is one of the most difficult conditions to treat. Make sure you check in with a medical professional before pursuing any ketamine treatments. The bill also prohibits employers from discriminating against workers who use cannabis in their off time—as long as it does not affect job performance.

Chronic Pain 97

Chronic Pain Data Consumption Safety 97

Cannabis Law Report

FEBRUARY 19, 2022

Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers. Advocates now have turned their sights to the 2024 election cycle. Louisiana has had a limited medical cannabis program since 2020.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

The Blunt Truth

JANUARY 5, 2022

Most Philadelphia employers are now prohibited from requiring prospective employees to undergo testing for the presence of marijuana as a condition of employment. Retail sales will not begin until January 1, 2024. Philadelphia. Currently, only New York City and Nevada have similar marijuana testing restrictions.

Law 105

Law Marijuana Policy Recreational 105

Kind Meds (Cannabis Education Blog)

JULY 25, 2024

Insomnia (difficulty falling or staying asleep) is a pervasive medical condition, affecting nearly a third of all adults globally. However, there are many years of medical research and study behind the science of sleeplessness already, so human knowledge on the topic and its treatments is fairly advanced. The best terpenes for sleep.

Terpenes 69

Terpenes Sleep Strains Cannabinoids 69

PrestoDoctor

JUNE 2, 2020

Forecasts state that the medical marijuana market will be worth more than $8 billion by 2024, and the global medical cannabis market is predicted to reach a net worth of $73.6 During the meeting, you can state to the doctor why you want a medical marijuana card, and what existing conditions you have. billion by 2027. Where to Go.

Marijuana 52

Marijuana Epilepsy Conditions Chronic Pain 52

Cannabis Law Report

AUGUST 18, 2021

This statewide change follows New York City ’s April 2019 ban on pre-employment cannabis testing, which deems screening for marijuana or THC as a condition of employment to be an unlawful discriminatory practice, with limited exceptions. The retail sale of marijuana in Virginia, however, will not begin until January 1, 2024.

Legislation 105

Legislation Legalization Marijuana Recreational 105

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK.

Therapy 52

Therapy Access Patients Treatment 52

The Blunt Truth

APRIL 20, 2021

Retail sales will not begin until January 1, 2024. Beginning on July 1, 2021, the Virginia Cannabis Control Act (CCA) will allow those 21 years of age or older to possess up to one ounce of cannabis and to cultivate up to four cannabis plants per household for personal use.

Recreational 77

Recreational Legalization Oil Extraction 77

Veriheal

MARCH 31, 2022

Kathy Hochul signed legislation establishing a conditional cultivation and processing recreational licensing structure. Kathy Hochul signed legislation properly establishing a conditional cultivation and processing recreational cannabis licensing structure. The deadline date for issuing conditional licenses is Dec.

Recreational 52

Recreational Cultivation Conditions Agriculture 52

The Blunt Truth

OCTOBER 24, 2019

The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Speaking of Connecticut, the state just added several conditions to the list of permissible uses of medical marijuana.

Hemp 58

Hemp DEA CBD Topical 58

Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). billion by 2024.

Legalization 75

Legalization Advocacy Legislation Recreational 75

Cannabis Law Report

DECEMBER 14, 2019

billion by 2024. The UK medicinal cannabis market value is forecast to reach almost US$1.3 Prohibition Partners’ has also estimated that up to 1 per-cent of the UK population could qualify as medical cannabis patients by 2028.

Pharmaceutical 45

Pharmaceutical Chronic Pain Patients Epilepsy 45

Cannabis Law Report

NOVEMBER 29, 2021

The retail provisions are set to take effect on January 1, 2024, but this deadline could be expedited by lawmakers. House Bill 89 : This legislation expanded the pool of qualifying conditions for medical cannabis to include moderate to severe insomnia and autism spectrum disorder. DECRIMINALIZATION. It took effect June 24, 2021.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

MAY 31, 2022

Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

MMJ Recs

JUNE 1, 2024

Under this law, cities were required to adopt new ordinances by January 2024 to allow for medical cannabis delivery to patients and their primary caregivers. Consistent Supply: Cannabis delivery services help ensure a consistent supply of medication for patients, particularly those with chronic conditions or ongoing treatment needs.

Access 52

Access Patients Medicine Dispensary 52

Cannabis Law Report

JANUARY 3, 2022

Most Philadelphia employers are now prohibited from requiring prospective employees to undergo testing for the presence of marijuana as a condition of employment. Retail sales will not begin until January 1, 2024. Philadelphia. Currently, only New York City and Nevada have similar marijuana testing restrictions.

Law 52

Law Marijuana Policy Recreational 52

SpeedWeed

MARCH 15, 2021

In short, cannabis went from an alternative treatment to an essential medicine, giving it a major upgrade in credibility. You can look at the demographics and see how many people are approaching the plant with something in mind; with joint pain, anxiety, with trying to manage a condition. 1, 2024, start.

Marijuana 52

Marijuana Banking Recreational Business 52

Cannabis Law Report

SEPTEMBER 22, 2022

Under this bill, the Veterinary Medical Board is required to adopt guidelines, by January 1, 2024, for veterinarians to follow when recommending cannabis within the veterinarian-client-patient relationship, and would require the Veterinary Medical Board to post the guidelines on its internet website. AB 2568 – Cannabis: Insurance Providers.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

JUNE 30, 2019

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. billion in 2024, nearly triple the US$14.9 billion estimated for this year.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

The Joint Blog

JANUARY 8, 2020

The initial four formulations handed out are used for treating conditions such as migraines, insomnia, nausea, numbness and pain. billion by 2024. The treatment isn’t widely available and the cost is quite high if you visit underground clinics, but this service is free and anyone can access it,” she said.

Marijuana 26

Marijuana Oil Patients Medicine 26

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Second investment grade credit rating from Fitch Ratings after the one secured with Moody’s last year.

Business 81

Business Research and Development Environment Food 81

The Joint Blog

JANUARY 4, 2022

However, just because CBD has shown promise as a treatment for some disorders doesn’t mean it’s some miracle cure-all as some overeager marketers make it to be. As a result, the CBD market is projected to be worth more than USD$24 billion by the year 2024. . CBD Chewables And Edibles Versus Other CBD Forms.

CBD 26

CBD Edibles Vaping Oil 26

Illinois News Joint

JANUARY 13, 2025

Our readers and followers reacted the most to the one positive story about the Illinois Department of Public Health (IDPH) adding four new conditions to the list of qualifying debilitating condition for medical patients in the Compassionate Use of Medical Cannabis Program. 7, 2023, but did not meet again until March 11, 2024.

Conditions 105

Conditions Patients Treatment Programs 105

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Veriheal

OCTOBER 1, 2020

The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy. Naturally, this enraged the public since both of the children found failure in other medications before they found victory in cannabis as a treatment for their condition.

Legalization 105

Legalization Oil Medicine Media 105

Canna Law Blog

MARCH 11, 2024

HB 1453 seeks to alleviate the unfair tax burden on medical cannabis patients and providers On March 6, 2024, the Washington Senate passed HB 1453 which will provide an exemption from the 37% excise tax for medical cannabis patients and designated providers. The bill now waits for signatures and executive action to become law.

Chronic Pain 111

Chronic Pain Recreational Patients Medicine 111

Veriheal

FEBRUARY 11, 2025

This long-anticipated development marks a major shift in Kentuckys stance on cannabis, opening new doors for patients seeking alternative treatments. In early 2024, a bill was signed by Kentuckys Governor to expedite the cannabis licensing process ahead by six months so the new medical cannabis market launch could also happen sooner.

Marijuana 59

Marijuana Dispensary Programs Patients 59

Cannabis Law Report

SEPTEMBER 12, 2022

Government Agencies seek funding to research cannabinoids as treatments for various conditions: [link]. Virginia 2024 adult use program may be postponed: [link]. Louisiana allows doctors to decide conditions: [link]. My latest selection of links to articles and updates around the country in August. Cannabinoids.

DEA 98

DEA Hemp Dispensary Therapy 98

The Cannigma

FEBRUARY 21, 2021

billion by 2024. Some of the largest companies in cannabis, like Tilray , invest heavily in research and development of medical cannabis products and treatments. A large body of research has made abundantly clear, however, that it can benefit a large number of medical conditions and symptoms. The power of federal reform.

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118

The Blunt Truth

OCTOBER 3, 2019

In Connecticut , meanwhile, the state may add chronic pain to the list of conditions eligible for treatment with medical marijuana. ” Since the CBD industry is projected to surpass $20 billion by 2024 , those tests might come in handy. Note that McConnell still refers to marijuana as hemp’s “illicit cousin.”

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Cannabis Law Report

SEPTEMBER 16, 2022

The program is a “limited license” regime, under which a set number of vertically integrated “Medical Marijuana Treatment Centers” are licensed to cultivate, process, and dispense cannabis to qualified patients. Patients are expected to have access to product in late 2023 or early 2024. In 2021, more than $1.2 Code §§ 20-2A-1.

Law 52

Law Programs Cultivation Dispensary 52